LEE SPAIN: Open Payments
NPI 1427281559 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,648 in 208 payments from 18 companies in 2025. Trend: 2023 $1,909 · 2024 $2,577 · 2025 $3,648
Food & beverage: $3,456Education: $191
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 67 | $1,042 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $488 |
| Alkermes, Inc. | 23 | $371 |
| Neurocrine BioSciences, Inc. | 12 | $278 |
| E.R. Squibb & Sons, L.L.C. | 16 | $220 |
| Axsome Therapeutics, Inc. | 17 | $219 |
| Lundbeck LLC | 12 | $204 |
| Vanda Pharmaceuticals Inc. | 9 | $185 |
| Otsuka America Pharmaceutical, Inc. | 14 | $185 |
| ABBVIE INC. | 5 | $96 |
Products named: CAPLYTA, UZEDY, REXULTI, ARISTADA, AUSTEDO XR, INGREZZA, Auvelity, COBENFY.
Industry payments across PA — which companies pay providers there.
